These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11745926)
1. Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users. Amendola A; Boschini A; Colzani D; Anselmi G; Oltolina A; Zucconi R; Begnini M; Besana S; Tanzi E; Zanetti AR J Med Virol; 2001 Dec; 65(4):644-8. PubMed ID: 11745926 [TBL] [Abstract][Full Text] [Related]
2. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995 [TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Amendola A; Tanzi E; Zappa A; Colzani D; Boschini A; Musher DM; Zanetti AR Vaccine; 2002 Nov; 20(31-32):3720-4. PubMed ID: 12399200 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. Iorio AM; Alatri A; Francisci D; Preziosi R; Neri M; Donatelli I; Castrucci MR; Biasio LR; Tascini C; Iapoce R; Pierucci P; Baldelli F Vaccine; 1997 Jan; 15(1):97-102. PubMed ID: 9041673 [TBL] [Abstract][Full Text] [Related]
5. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335 [TBL] [Abstract][Full Text] [Related]
6. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients. Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520 [TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Fuller JD; Craven DE; Steger KA; Cox N; Heeren TC; Chernoff D Clin Infect Dis; 1999 Mar; 28(3):541-7. PubMed ID: 10194075 [TBL] [Abstract][Full Text] [Related]
8. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza. Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344 [TBL] [Abstract][Full Text] [Related]
9. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. McKittrick N; Frank I; Jacobson JM; White CJ; Kim D; Kappes R; DiGiorgio C; Kenney T; Boyer J; Tebas P Ann Intern Med; 2013 Jan; 158(1):19-26. PubMed ID: 23277897 [TBL] [Abstract][Full Text] [Related]
10. Compromised B cell responses to influenza vaccination in HIV-infected individuals. Malaspina A; Moir S; Orsega SM; Vasquez J; Miller NJ; Donoghue ET; Kottilil S; Gezmu M; Follmann D; Vodeiko GM; Levandowski RA; Mican JM; Fauci AS J Infect Dis; 2005 May; 191(9):1442-50. PubMed ID: 15809902 [TBL] [Abstract][Full Text] [Related]
11. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy. Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772 [TBL] [Abstract][Full Text] [Related]
12. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. Kroon FP; van Dissel JT; de Jong JC; van Furth R AIDS; 1994 Apr; 8(4):469-76. PubMed ID: 7912086 [TBL] [Abstract][Full Text] [Related]